Department of Communicable Disease Surveillance and Control, Ministry of Health, Muscat, Oman.
East Mediterr Health J. 2010 May;16(5):474-80.
A descriptive record-based review of adverse events following immunization (AEFI) was carried out in Oman using the national database for the period 1996-2005. A total of 790 adverse event reports were received with an annual rate during the review period of 33.7 per 100 000 population or 10.8 per 100 000 doses administered. There were no reported deaths. The most frequently reported AEFI were BCG adenitis (69.7 per 100 000 doses) and local reactions (3.6 per 100 000 doses respectively). The statistically significant higher rates among males, in children aged > 2 years and in some sparsely populated regions of Oman need further research. AEFI rates in Oman were similar or below the international averages
对 1996 年至 2005 年期间全国不良事件监测系统的监测数据进行了分析。共收到 790 份不良事件报告，报告发生率为 33.7/10 万，其中卡介苗（BCG）接种后淋巴结炎报告发生率为 69.7/10 万，局部反应报告发生率为 3.6/10 万。无死亡病例报告。男童、年龄大于 2 岁儿童和部分偏远地区不良事件报告发生率相对较高，需要进一步研究。阿曼的不良事件报告发生率与国际平均水平相似或低于国际平均水平。
